983P Camrelizumab (C) in combination with apatinib (A) in patients with advanced hepatocellular carcinoma (RESCUE): An open-label, multi-center, phase II trialJ. Xu, Qi Wang, Shanzhi Gu et al.|Annals of Oncology|2020Cited by 5